<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37532784</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1745-7254</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Acta pharmacologica Sinica</Title><ISOAbbreviation>Acta Pharmacol Sin</ISOAbbreviation></Journal><ArticleTitle>Phenome-wide association study and precision medicine of cardiovascular diseases in the post-COVID-19 era.</ArticleTitle><Pagination><StartPage>2347</StartPage><EndPage>2357</EndPage><MedlinePgn>2347-2357</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41401-023-01119-1</ELocationID><Abstract><AbstractText>SARS-CoV-2 infection causes injuries of not only the lungs but also the heart and endothelial cells in vasculature of multiple organs, and induces systemic inflammation and immune over-reactions, which makes COVID-19 a disease phenome that simultaneously affects multiple systems. Cardiovascular diseases (CVD) are intrinsic risk and causative factors for severe COVID-19 comorbidities and death. The wide-spread infection and reinfection of SARS-CoV-2 variants and the long-COVID may become a new common threat to human health and propose unprecedented impact on the risk factors, pathophysiology, and pharmacology of many diseases including CVD for a long time. COVID-19 has highlighted the urgent demand for precision medicine which needs new knowledge network to innovate disease taxonomy for more precise diagnosis, therapy, and prevention of disease. A deeper understanding of CVD in the setting of COVID-19 phenome requires a paradigm shift from the current phenotypic study that focuses on the virus or individual symptoms to phenomics of COVID-19 that addresses the inter-connectedness of clinical phenotypes, i.e., clinical phenome. Here, we summarize the CVD manifestations in the full clinical spectrum of COVID-19, and the phenome-wide association study of CVD interrelated to COVID-19. We discuss the underlying biology for CVD in the COVID-19 phenome and the concept of precision medicine with new phenomic taxonomy that addresses the overall pathophysiological responses of the body to the SARS-CoV-2 infection. We also briefly discuss the unique taxonomy of disease as Zheng-hou patterns in traditional Chinese medicine, and their potential implications in precision medicine of CVD in the post-COVID-19 era.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cao</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Du</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jiang</LastName><ForeName>Xiao-Yan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Chen-Hao</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zi-Yu</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Xing-Xing</ForeName><Initials>XX</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao-Qiang</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Lingyu Linda</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China. lye@swmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, 646000, China. lye@swmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Autoimmune Diseases and Precision Medicie, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, 750001, China. lye@swmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Dayue Darrel</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Center for Phenomics of Traditional Chinese Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China. dduan@swmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, 646000, China. dduan@swmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Autoimmune Diseases and Precision Medicie, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, 750001, China. dduan@swmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Department of Pharmacology, University of Nevada Reno School of Medicine, Reno, NV, 89557, USA. dduan@swmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Acta Pharmacol Sin</MedlineTA><NlmUniqueID>100956087</NlmUniqueID><ISSNLinking>1671-4083</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080444" MajorTopicYN="N">Phenomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PheWAS</Keyword><Keyword MajorTopicYN="N">Traditional Chinese Medicine</Keyword><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">precision medicine</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37532784</ArticleId><ArticleId IdType="pmc">PMC10692238</ArticleId><ArticleId IdType="doi">10.1038/s41401-023-01119-1</ArticleId><ArticleId IdType="pii">10.1038/s41401-023-01119-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727&#x2013;33. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270&#x2013;3. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XL, Li ZM, Ye JT, Lu J, Ye LL, Zhang CX, et al. Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives. Acta Pharmacol Sin. 2020;41:1377&#x2013;86. doi: 10.1038/s41401-020-00519-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-00519-x</ArticleId><ArticleId IdType="pmc">PMC7509225</ArticleId><ArticleId IdType="pubmed">32968208</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluckman TJ, Bhave NM, Allen LA, Chung EH, Spatz ES, Ammirati E, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022;79:1717&#x2013;56. doi: 10.1016/j.jacc.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Welty FK, Rajai N, Amangurbanova M. Comprehensive review of cardiovascular complications of coronavirus disease 2019 and beneficial treatments. Cardiol Rev. 2022;30:145&#x2013;57. doi: 10.1097/CRD.0000000000000422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000422</ArticleId><ArticleId IdType="pmc">PMC8983616</ArticleId><ArticleId IdType="pubmed">35384908</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho HT, Peischard S, Strutz-Seebohm N, Klingel K, Seebohm G. Myocardial damage by SARS-CoV-2: emerging mechanisms and therapies. Viruses. 2021;13:1880&#x2013;903. doi: 10.3390/v13091880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091880</ArticleId><ArticleId IdType="pmc">PMC8473126</ArticleId><ArticleId IdType="pubmed">34578462</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A, Frati P, Del Duca F, Santoro P, Manetti AC, La Russa R, et al. Myocardial pathology in COVID-19-associated cardiac injury: a systematic review. Diagnostics. 2021;11:1647&#x2013;61. doi: 10.3390/diagnostics11091647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11091647</ArticleId><ArticleId IdType="pmc">PMC8472043</ArticleId><ArticleId IdType="pubmed">34573988</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooke JP, Connor JH, Jain A. Acute and chronic cardiovascular manifestations of COVID-19: role for endotheliopathy. Methodist Debakey Cardiovasc J. 2021;17:53&#x2013;62. doi: 10.14797/mdcvj.1044.</Citation><ArticleIdList><ArticleId IdType="doi">10.14797/mdcvj.1044</ArticleId><ArticleId IdType="pmc">PMC8680072</ArticleId><ArticleId IdType="pubmed">34992723</ArticleId></ArticleIdList></Reference><Reference><Citation>Arevalos V, Ortega-Paz L, Rodriguez-Arias JJ, Calvo Lopez M, Castrillo-Golvano L, Salazar-Rodriguez A, et al. Acute and chronic effects of COVID-19 on the cardiovascular system. J Cardiovasc Dev Dis. 2021;8:128&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8541609</ArticleId><ArticleId IdType="pubmed">34677197</ArticleId></ArticleIdList></Reference><Reference><Citation>Crudo VL, Ahmed AI, Cowan EL, Shah DJ, Al-Mallah MH, Malahfji M. Acute and subclinical myocardial injury in COVID-19. Methodist Debakey Cardiovasc J. 2021;17:22&#x2013;30. doi: 10.14797/mdcvj.1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.14797/mdcvj.1038</ArticleId><ArticleId IdType="pmc">PMC8680173</ArticleId><ArticleId IdType="pubmed">34992721</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal V, Sarfraz Z, Sarfraz A, Mukherjee D, Batra N, Hitawala G, et al. COVID-19 infection and myocarditis: a state-of-the-art systematic review. J Prim Care Community Health. 2021;12:21501327211056800. doi: 10.1177/21501327211056800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211056800</ArticleId><ArticleId IdType="pmc">PMC8647231</ArticleId><ArticleId IdType="pubmed">34854348</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YM, Zheng Y, Yu Y, Wang Y, Huang Q, Qian F, et al. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage. EMBO J. 2020;39:e105896. doi: 10.15252/embj.2020105896.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020105896</ArticleId><ArticleId IdType="pmc">PMC7737620</ArticleId><ArticleId IdType="pubmed">33140861</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler NG, Gray N, Kimhofer T, Boughton B, Gay M, Yang R, et al. Systemic perturbations in amine and kynurenine metabolism associated with acute SARS-CoV-2 infection and inflammatory cytokine responses. J Proteome Res. 2021;20:2796&#x2013;811. doi: 10.1021/acs.jproteome.1c00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00052</ArticleId><ArticleId IdType="pubmed">33724837</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Pan J, Zhang C, Sun X. Cardiovascular complications of COVID-19 vaccines. Front Cardiovasc Med. 2022;9:840929. doi: 10.3389/fcvm.2022.840929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.840929</ArticleId><ArticleId IdType="pmc">PMC8971371</ArticleId><ArticleId IdType="pubmed">35369340</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi A, Balan I, Yadav S, Matos WF, Kharawala A, Gaddam M, et al. Post-COVID-19 pulmonary fibrosis. Cureus. 2022;14:e22770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8974316</ArticleId><ArticleId IdType="pubmed">35371880</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulou A, Musa H, Sivaganesan M, McCoy D, Deloukas P, Marouli E. COVID-19 susceptibility variants associate with blood clots, thrombophlebitis and circulatory diseases. PLoS One. 2021;16:e0256988. doi: 10.1371/journal.pone.0256988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256988</ArticleId><ArticleId IdType="pmc">PMC8415605</ArticleId><ArticleId IdType="pubmed">34478452</ArticleId></ArticleIdList></Reference><Reference><Citation>Parise RS, Ramesh S, Govindarajulu M, Ajoolabady A, Moore T, Dhanasekaran M. COVID-19-induced cardiovascular damage differs from other prevalent viruses. Cardiol Plus. 2021;6:231&#x2013;45. doi: 10.4103/2470-7511.334401.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2470-7511.334401</ArticleId><ArticleId IdType="pmc">PMC8958943</ArticleId><ArticleId IdType="pubmed">35368975</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Kahwash R, Tong MS, Paschke K, Satoskar AA, Foreman B, et al. Fulminant myocarditis following SARS-CoV-2 infection: JACC patient care pathways. JACC Case Rep. 2022;4:567&#x2013;75. doi: 10.1016/j.jaccas.2022.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2022.03.013</ArticleId><ArticleId IdType="pmc">PMC8961314</ArticleId><ArticleId IdType="pubmed">35373150</ArticleId></ArticleIdList></Reference><Reference><Citation>Regan JA, Abdulrahim JW, Bihlmeyer NA, Haynes C, Kwee LC, Patel MR, et al. Phenome-wide association study of severe COVID-19 genetic risk variants. J Am Heart Assoc. 2022;11:e024004. doi: 10.1161/JAHA.121.024004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.024004</ArticleId><ArticleId IdType="pmc">PMC9075057</ArticleId><ArticleId IdType="pubmed">35179038</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Giovini M, Leone M, Pizzilli G, Kortgen A, Bauer M, et al. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann Intensive Care. 2020;10:124. doi: 10.1186/s13613-020-00741-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00741-0</ArticleId><ArticleId IdType="pmc">PMC7492788</ArticleId><ArticleId IdType="pubmed">32953201</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B, Asatryan B, Hanff TC, Chatha SR, Khanji MY, Ricci F, et al. The pathogenesis and long-term consequences of COVID-19 cardiac injury. JACC Basic Transl Sci. 2022;7:294&#x2013;308. doi: 10.1016/j.jacbts.2021.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.10.011</ArticleId><ArticleId IdType="pmc">PMC8828362</ArticleId><ArticleId IdType="pubmed">35165665</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Gamazon ER. Integrative transcriptomic, evolutionary, and causal inference framework for region-level analysis: Application to COVID-19. NPJ Genom Med. 2022;7:24. doi: 10.1038/s41525-022-00296-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-022-00296-y</ArticleId><ArticleId IdType="pmc">PMC8940898</ArticleId><ArticleId IdType="pubmed">35318325</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YP, Zhang YY, Duan DD. From genome-wide association study to phenome-wide association study: new paradigms in obesity research. Prog Mol Biol Transl Sci. 2016;140:185&#x2013;231. doi: 10.1016/bs.pmbts.2016.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2016.02.003</ArticleId><ArticleId IdType="pubmed">27288830</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A, Tsao NL, Thomann L, Ho YL, Iyengar S, Luoh SW, et al. A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program. PLoS Genet. 2022;18:e1010113. doi: 10.1371/journal.pgen.1010113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1010113</ArticleId><ArticleId IdType="pmc">PMC9049369</ArticleId><ArticleId IdType="pubmed">35482673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuta-Quintero E, Martinez-Ayala C, Mantilla-Beltran G, Rueda-Rodriguez A, Pimentel J. Multisystem inflammatory syndrome and COVID-19: a scoping review. Bol Med Hosp Infant Mex. 2022;79:69&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">35073627</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan DD, Han Y, Li L, Zhao J, Wang Z. Pharmacophenomics: a new paradigm for pharmacology, toxicology, and personalized medicine. Chin J Pharmacol Toxicol. 2014;28:1&#x2013;9.</Citation></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583&#x2013;90. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson JK. Molecular phenomic approaches to deconvolving the systemic effects of SARS-CoV-2 infection and post-acute COVID-19 syndrome. Phenomics. 2021;1:143&#x2013;50. doi: 10.1007/s43657-021-00020-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43657-021-00020-3</ArticleId><ArticleId IdType="pmc">PMC8295979</ArticleId><ArticleId IdType="pubmed">35233558</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelsayed N, McKinney B, Carter M. SARS-CoV-2 complicated by a large hemorrhagic pericardial effusion. Cureus. 2022;14:e22282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8932404</ArticleId><ArticleId IdType="pubmed">35350491</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med. 2022;54:524&#x2013;40. doi: 10.1080/07853890.2022.2031274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2031274</ArticleId><ArticleId IdType="pmc">PMC8843115</ArticleId><ArticleId IdType="pubmed">35132910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MS, Shaik RA, Ahmad RK, Yusuf M, Khan M, Almutairi AB, et al. &#x201c;LONG COVID&#x201d;: an insight. Eur Rev Med Pharm Sci. 2021;25:5561&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">34533807</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiravi AA, Ardekani A, Sheikhbahaei E, Heshmat-Ghahdarijani K. Cardiovascular complications of SARS-CoV-2 vaccines: an overview. Cardiol Ther. 2022;11:13&#x2013;21. doi: 10.1007/s40119-021-00248-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40119-021-00248-0</ArticleId><ArticleId IdType="pmc">PMC8629102</ArticleId><ArticleId IdType="pubmed">34845662</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;9. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020;41:1798&#x2013;800. doi: 10.1093/eurheartj/ehaa231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa231</ArticleId><ArticleId IdType="pmc">PMC7454513</ArticleId><ArticleId IdType="pubmed">32186331</ArticleId></ArticleIdList></Reference><Reference><Citation>Parohan M, Yaghoubi S, Seraji A. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Eur Heart J Acute Cardiovasc Care. 2020;9:665&#x2013;77. doi: 10.1177/2048872620937165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872620937165</ArticleId><ArticleId IdType="pmc">PMC7678334</ArticleId><ArticleId IdType="pubmed">32567326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. Prevalence and impact of myocardial injury in patients hospitalized With COVID-19 infection. J Am Coll Cardiol. 2020;76:533&#x2013;46. doi: 10.1016/j.jacc.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Garcia J, Lee S, Gupta A, Cagliostro M, Joshi AA, Rivas-Lasarte M, et al. Prognostic impact of prior heart failure in patients hospitalized with COVID-19. J Am Coll Cardiol. 2020;76:2334&#x2013;48. doi: 10.1016/j.jacc.2020.09.549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.09.549</ArticleId><ArticleId IdType="pmc">PMC7598769</ArticleId><ArticleId IdType="pubmed">33129663</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G, Pinney SP, Lala A, Reddy VY, Johnston-Cox HA, Mechanick JI, et al. Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar. J Am Coll Cardiol. 2020;76:2011&#x2013;23. doi: 10.1016/j.jacc.2020.08.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.059</ArticleId><ArticleId IdType="pmc">PMC7572122</ArticleId><ArticleId IdType="pubmed">33092737</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Xu D, Fu S, Zhang J, Yang X, Xu L, et al. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study. Crit Care. 2020;24:219. doi: 10.1186/s13054-020-02939-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02939-x</ArticleId><ArticleId IdType="pmc">PMC7223395</ArticleId><ArticleId IdType="pubmed">32410714</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;42. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708&#x2013;20. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666&#x2013;87. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Saggese CE. COVID-19 and stroke: an emerging association. Cerebrovasc Dis. 2021;50:363. doi: 10.1159/000514132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000514132</ArticleId><ArticleId IdType="pmc">PMC8089418</ArticleId><ArticleId IdType="pubmed">33735901</ArticleId></ArticleIdList></Reference><Reference><Citation>Saggese CE, Del Bianco C, Di Ruzza MR, Magarelli M, Gandini R, Plocco M. COVID-19 and stroke: casual or causal role? Cerebrovasc Dis. 2020;49:341&#x2013;4. doi: 10.1159/000509453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509453</ArticleId><ArticleId IdType="pmc">PMC7445378</ArticleId><ArticleId IdType="pubmed">32634813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kario K, Morisawa Y, Sukonthasarn A, Turana Y, Chia YC, Park S, et al. COVID-19 and hypertension-evidence and practical management: guidance from the HOPE Asia Network. J Clin Hypertens. 2020;22:1109&#x2013;19. doi: 10.1111/jch.13917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jch.13917</ArticleId><ArticleId IdType="pmc">PMC7361740</ArticleId><ArticleId IdType="pubmed">32643874</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430&#x2013;6. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020;323:2195&#x2013;8. doi: 10.1001/jama.2020.7202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.7202</ArticleId><ArticleId IdType="pmc">PMC7182961</ArticleId><ArticleId IdType="pubmed">32329797</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Bastarache L, Roden DM. Phenome-wide association studies as a tool to advance precision medicine. Annu Rev Genom Hum Genet. 2016;17:353&#x2013;73. doi: 10.1146/annurev-genom-090314-024956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genom-090314-024956</ArticleId><ArticleId IdType="pmc">PMC5480096</ArticleId><ArticleId IdType="pubmed">27147087</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatore M, Gu T, Mack JA, Prabhu Sankar S, Patil S, Valley TS, et al. A Phenome-Wide Association Study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan medicine. J Clin Med. 2021;10:1351. doi: 10.3390/jcm10071351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10071351</ArticleId><ArticleId IdType="pmc">PMC8037108</ArticleId><ArticleId IdType="pubmed">33805886</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A, Tsao NL, Thomann LO, Ho YL, Iyengar SK, Luoh SW, et al. A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program. PLoS Genet. 2022;18:e1010113. doi: 10.1371/journal.pgen.1010113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1010113</ArticleId><ArticleId IdType="pmc">PMC9049369</ArticleId><ArticleId IdType="pubmed">35482673</ArticleId></ArticleIdList></Reference><Reference><Citation>Song RJ, Ho YL, Schubert P, Park Y, Posner D, Lord EM, et al. Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program. PLoS One. 2021;16:e0251651. doi: 10.1371/journal.pone.0251651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251651</ArticleId><ArticleId IdType="pmc">PMC8118298</ArticleId><ArticleId IdType="pubmed">33984066</ArticleId></ArticleIdList></Reference><Reference><Citation>George G, Gan S, Huang Y, Appleby P, Nar AS, Venkatesan R, et al. PheGWAS: a new dimension to visualize GWAS across multiple phenotypes. Bioinformatics. 2020;36:2500&#x2013;5. doi: 10.1093/bioinformatics/btz944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz944</ArticleId><ArticleId IdType="pmc">PMC7178436</ArticleId><ArticleId IdType="pubmed">31860083</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergrass SA, Brown-Gentry K, Dudek S, Frase A, Torstenson ES, Goodloe R, et al. Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) network. PLoS Genet. 2013;9:e1003087. doi: 10.1371/journal.pgen.1003087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003087</ArticleId><ArticleId IdType="pmc">PMC3561060</ArticleId><ArticleId IdType="pubmed">23382687</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayol A, Livrozet M, Boutouyrie P, Khettab H, Betton M, Tea V, et al. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study. ESC Heart Fail. 2021;8:2232&#x2013;9. doi: 10.1002/ehf2.13315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13315</ArticleId><ArticleId IdType="pmc">PMC8120370</ArticleId><ArticleId IdType="pubmed">33773099</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolis AS, Manolis AA, Manolis TA, Apostolopoulos EJ, Papatheou D, Melita H. COVID-19 infection and cardiac arrhythmias. Trends Cardiovasc Med. 2020;30:451&#x2013;60. doi: 10.1016/j.tcm.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7429078</ArticleId><ArticleId IdType="pubmed">32814095</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti-Infective Ther. 2021;19:345&#x2013;57. doi: 10.1080/14787210.2020.1822737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2020.1822737</ArticleId><ArticleId IdType="pubmed">32921216</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahranavard M, Akhavan Rezayat A, Zamiri Bidary M, Omranzadeh A, Rohani F, Hamidi Farahani R, et al. Cardiac complications in COVID-19: a systematic review and meta-analysis. Arch Iran Med. 2021;24:152&#x2013;63. doi: 10.34172/aim.2021.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/aim.2021.24</ArticleId><ArticleId IdType="pubmed">33636985</ArticleId></ArticleIdList></Reference><Reference><Citation>Haussner W, DeRosa AP, Haussner D, Tran J, Torres-Lavoro J, Kamler J, et al. COVID-19 associated myocarditis: a systematic review. Am J Emerg Med. 2022;51:150&#x2013;5. doi: 10.1016/j.ajem.2021.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.10.001</ArticleId><ArticleId IdType="pmc">PMC8531234</ArticleId><ArticleId IdType="pubmed">34739868</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, MacDonald-Dunlop E, Chen J, Zhai R, Li T, Richmond A, et al. Genetic landscape of the ACE2 coronavirus receptor. Circulation. 2022;145:1398&#x2013;411. doi: 10.1161/CIRCULATIONAHA.121.057888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.057888</ArticleId><ArticleId IdType="pmc">PMC9047645</ArticleId><ArticleId IdType="pubmed">35387486</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekharzadeh P, Patel A, Sokolova E, Rodas A, Ahmed S. Takotsubo cardiomyopathy: a COVID-19 complication. Cureus. 2022;14:e22803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8980236</ArticleId><ArticleId IdType="pubmed">35399473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, Rahimi O, Gupta N, Ahsan C. Complete AV block in vaccinated COVID-19 patient. Case Rep Cardiol. 2022;2022:9371818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8965601</ArticleId><ArticleId IdType="pubmed">35371571</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh T, Khan H, Gamble DT, Scally C, Newby DE, Dawson D. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications. Circulation. 2022;145:1002&#x2013;19. doi: 10.1161/CIRCULATIONAHA.121.055854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.055854</ArticleId><ArticleId IdType="pmc">PMC7612566</ArticleId><ArticleId IdType="pubmed">35344411</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez JMD, Nair G, Nanavaty P, Rao A, Marinescu K, Suboc T. COVID-19-associated takotsubo cardiomyopathy. BMJ Case Rep. 2020;13:e236811. doi: 10.1136/bcr-2020-236811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-236811</ArticleId><ArticleId IdType="pmc">PMC7735089</ArticleId><ArticleId IdType="pubmed">33310830</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139:e891&#x2013;e908. doi: 10.1161/CIR.0000000000000670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000670</ArticleId><ArticleId IdType="pubmed">30913893</ArticleId></ArticleIdList></Reference><Reference><Citation>Chammas J, Delaney D, Chabaytah N, Abdulkarim S, Schwertani A. COVID-19 and the cardiovascular system: insights into effects and treatments. Can J Physiol Pharmacol. 2021;99:1119&#x2013;27. doi: 10.1139/cjpp-2021-0093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2021-0093</ArticleId><ArticleId IdType="pubmed">34546123</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;5. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:819&#x2013;24. doi: 10.1001/jamacardio.2020.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Dong Y, Wang H, Guo W, Zhou H, Zhang Z, et al. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Nutr Metab Cardiovasc Dis. 2020;30:1061&#x2013;7. doi: 10.1016/j.numecd.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7165120</ArticleId><ArticleId IdType="pubmed">32456948</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid M, Awan S, Jatoi NN, Jatoi HN, Yasmin F, Ochani RK, et al. Cardiac manifestations of the coronavirus disease-19: a review of pathogenesis, clinical manifestations, diagnosis, and treatment. Pan Afr Med J. 2021;39:173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8449581</ArticleId><ArticleId IdType="pubmed">34584599</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215&#x2013;20. doi: 10.1038/s41586-020-2180-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang RD, Liu MQ, Chen Y, Shan C, Zhou YW, Shen XR, et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell. 2020;182:50&#x2013;8. doi: 10.1016/j.cell.2020.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.027</ArticleId><ArticleId IdType="pmc">PMC7241398</ArticleId><ArticleId IdType="pubmed">32516571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;80. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181:894&#x2013;904. doi: 10.1016/j.cell.2020.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7144619</ArticleId><ArticleId IdType="pubmed">32275855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel UO, Kintscher U. ACE2 and SARS-CoV-2: tissue or plasma, good or bad? Am J Hypertens. 2021;34:274&#x2013;7. doi: 10.1093/ajh/hpaa175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpaa175</ArticleId><ArticleId IdType="pmc">PMC7665354</ArticleId><ArticleId IdType="pubmed">33151267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicik Z, Eyileten C, Jakubik D, Simoes SN, Martins DC, Jr, Pavao R, et al. ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factors. J Clin Med. 2020;9:3743&#x2013;72. doi: 10.3390/jcm9113743.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9113743</ArticleId><ArticleId IdType="pmc">PMC7700637</ArticleId><ArticleId IdType="pubmed">33233425</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehbe Z, Hammoud S, Soudani N, Zaraket H, El-Yazbi A, Eid AH. Molecular insights Into SARS COV-2 interaction with cardiovascular disease: role of RAAS and MAPK signaling. Front Pharmacol. 2020;11:836. doi: 10.3389/fphar.2020.00836.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00836</ArticleId><ArticleId IdType="pmc">PMC7283382</ArticleId><ArticleId IdType="pubmed">32581799</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004;25:291&#x2013;4. doi: 10.1016/j.tips.2004.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2004.04.001</ArticleId><ArticleId IdType="pmc">PMC7119032</ArticleId><ArticleId IdType="pubmed">15165741</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23:3&#x2013;20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631&#x2013;7. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner AJ, Nalivaeva NN. Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation. Peptides. 2022;151:170766. doi: 10.1016/j.peptides.2022.170766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2022.170766</ArticleId><ArticleId IdType="pmc">PMC8830188</ArticleId><ArticleId IdType="pubmed">35151768</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner AJ, Hooper NM. The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci. 2002;23:177&#x2013;83. doi: 10.1016/S0165-6147(00)01994-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-6147(00)01994-5</ArticleId><ArticleId IdType="pubmed">11931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang XC, Zhang HX, Zhang Z, Rinkiko S, Cui YM, Zhu YZ. The two-way switch role of ACE2 in the treatment of novel coronavirus pneumonia and underlying comorbidities. Molecules. 2020;26:142&#x2013;60. doi: 10.3390/molecules26010142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26010142</ArticleId><ArticleId IdType="pmc">PMC7794970</ArticleId><ArticleId IdType="pubmed">33396184</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126:1456&#x2013;74. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallentin L, Lindback J, Eriksson N, Hijazi Z, Eikelboom JW, Ezekowitz MD, et al. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. Eur Heart J. 2020;41:4037&#x2013;46. doi: 10.1093/eurheartj/ehaa697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa697</ArticleId><ArticleId IdType="pmc">PMC7543499</ArticleId><ArticleId IdType="pubmed">32984892</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63:364&#x2013;74. doi: 10.1007/s11427-020-1643-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1643-8</ArticleId><ArticleId IdType="pmc">PMC7088566</ArticleId><ArticleId IdType="pubmed">32048163</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornilov SA, Lucas I, Jade K, Dai CL, Lovejoy JC, Magis AT. Plasma levels of soluble ACE2are associated with sex, metabolic syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19. Crit Care. 2020;24:452. doi: 10.1186/s13054-020-03141-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03141-9</ArticleId><ArticleId IdType="pmc">PMC7373836</ArticleId><ArticleId IdType="pubmed">32698840</ArticleId></ArticleIdList></Reference><Reference><Citation>Sward P, Edsfeldt A, Reepalu A, Jehpsson L, Rosengren BE, Karlsson MK. Age and sex differences in soluble ACE2 may give insights for COVID-19. Crit Care. 2020;24:221. doi: 10.1186/s13054-020-02942-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02942-2</ArticleId><ArticleId IdType="pmc">PMC7224163</ArticleId><ArticleId IdType="pubmed">32410690</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Collins FS. Precision medicine in 2030-seven ways to transform healthcare. Cell. 2021;184:1415&#x2013;9. doi: 10.1016/j.cell.2021.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.015</ArticleId><ArticleId IdType="pmc">PMC9616629</ArticleId><ArticleId IdType="pubmed">33740447</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikpay M, Mohammadzadeh S. Phenome-wide screening for traits causally associated with the risk of coronary artery disease. J Hum Genet. 2020;65:371&#x2013;80. doi: 10.1038/s10038-019-0716-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s10038-019-0716-z</ArticleId><ArticleId IdType="pubmed">31907388</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Li L, Zhang Y, Yuan H, Ye L, Zhao J, et al. Phenomics of vascular disease: the systematic approach to the combination therapy. Curr Vasc Pharmacol. 2015;13:433&#x2013;40. doi: 10.2174/1570161112666141014144829.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570161112666141014144829</ArticleId><ArticleId IdType="pmc">PMC4397150</ArticleId><ArticleId IdType="pubmed">25313004</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Ritchie MD, Basford MA, Pulley JM, Bastarache L, Brown-Gentry K, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics. 2010;26:1205&#x2013;10. doi: 10.1093/bioinformatics/btq126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq126</ArticleId><ArticleId IdType="pmc">PMC2859132</ArticleId><ArticleId IdType="pubmed">20335276</ArticleId></ArticleIdList></Reference><Reference><Citation>Diogo D, Tian C, Franklin CS, Alanne-Kinnunen M, March M, Spencer CCA, et al. Phenome-wide association studies across large population cohorts support drug target validation. Nat Commun. 2018;9:4285. doi: 10.1038/s41467-018-06540-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06540-3</ArticleId><ArticleId IdType="pmc">PMC6191429</ArticleId><ArticleId IdType="pubmed">30327483</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergrass SA, Ritchie MD. Phenome-wide association studies: leveraging comprehensive phenotypic and genotypic data for discovery. Curr Genet Med Rep. 2015;3:92&#x2013;100. doi: 10.1007/s40142-015-0067-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40142-015-0067-9</ArticleId><ArticleId IdType="pmc">PMC4489156</ArticleId><ArticleId IdType="pubmed">26146598</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden DM. Phenome-wide association studies: a new method for functional genomics in humans. J Physiol. 2017;595:4109&#x2013;15. doi: 10.1113/JP273122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP273122</ArticleId><ArticleId IdType="pmc">PMC5471509</ArticleId><ArticleId IdType="pubmed">28229460</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnado A, Carroll RJ, Casey C, Wheless L, Denny JC, Crofford LJ. Phenome-wide association studies uncover a novel association of increased atrial fibrillation in male patients with systemic Lupus Erythematosus. Arthritis Care Res. 2018;70:1630&#x2013;6. doi: 10.1002/acr.23553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.23553</ArticleId><ArticleId IdType="pmc">PMC6109620</ArticleId><ArticleId IdType="pubmed">29481723</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak GA, Singh K, Miller-Fleming TW, Wendt FR, Ehsan N, Hou K, et al. Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization. Nat Commun. 2021;12:4569. doi: 10.1038/s41467-021-24824-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24824-z</ArticleId><ArticleId IdType="pmc">PMC8316582</ArticleId><ArticleId IdType="pubmed">34315903</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol. 2020;5:825&#x2013;30. doi: 10.1001/jamacardio.2020.1624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1624</ArticleId><ArticleId IdType="pmc">PMC7180726</ArticleId><ArticleId IdType="pubmed">32324209</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Wang Y, et al. Response by Zhang et al. to Letter Regarding Article, &#x201c;Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19&#x201d;. Circ Res. 2020;126:e142&#x2013;e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265881</ArticleId><ArticleId IdType="pubmed">32496914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126:1671&#x2013;81. doi: 10.1161/CIRCRESAHA.120.317134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317134</ArticleId><ArticleId IdType="pmc">PMC7265882</ArticleId><ArticleId IdType="pubmed">32302265</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins J. Preventing a covid-19 pandemic. BMJ. 2020;368:m810. doi: 10.1136/bmj.m810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m810</ArticleId><ArticleId IdType="pubmed">32111649</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020;41:1801&#x2013;3. doi: 10.1093/eurheartj/ehaa235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa235</ArticleId><ArticleId IdType="pmc">PMC7184407</ArticleId><ArticleId IdType="pubmed">32196087</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease In: Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. (National Academies Press (US), Washington, D.C., 2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22536618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chute CG, Celik C. Overview of ICD-11 architecture and structure. BMC Med Inform Decis Mak. 2022;21:378. doi: 10.1186/s12911-021-01539-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01539-1</ArticleId><ArticleId IdType="pmc">PMC9109286</ArticleId><ArticleId IdType="pubmed">35578335</ArticleId></ArticleIdList></Reference><Reference><Citation>Drosler SE, Weber S, Chute CG. ICD-11 extension codes support detailed clinical abstraction and comprehensive classification. BMC Med Inform Decis Mak. 2021;21:278. doi: 10.1186/s12911-021-01635-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01635-2</ArticleId><ArticleId IdType="pmc">PMC8577174</ArticleId><ArticleId IdType="pubmed">34753461</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JG, Xu H. Chinese medicine in fighting against Covid-19: role and inspiration. Chin J Integr Med. 2021;27:3&#x2013;6. doi: 10.1007/s11655-020-2860-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-020-2860-x</ArticleId><ArticleId IdType="pmc">PMC7792556</ArticleId><ArticleId IdType="pubmed">33420601</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Yin YH, Zhang MY, Liu JY, Li R, Qu YQ. Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology. Int J Med Sci. 2020;17:2511&#x2013;30. doi: 10.7150/ijms.46378.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.46378</ArticleId><ArticleId IdType="pmc">PMC7532482</ArticleId><ArticleId IdType="pubmed">33029094</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin YH, Zhan QY, Peng ZY, Ren XQ, Yin XT, Cai L, et al. Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version) Mil Med Res. 2020;7:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472403</ArticleId><ArticleId IdType="pubmed">32887670</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan DD, Wang Z, Zhang BL, Wang YY. Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine. Acta Pharmacol Sin. 2015;36:651&#x2013;3. doi: 10.1038/aps.2015.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2015.33</ArticleId><ArticleId IdType="pmc">PMC4594183</ArticleId><ArticleId IdType="pubmed">26036241</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan DD, Wang Z, Wang YY. New omic and network paradigms for deep understanding of therapeutic mechanisms for Fangji of traditional Chinese medicine. Acta Pharmacol Sin. 2018;39:903&#x2013;5. doi: 10.1038/aps.2018.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2018.42</ArticleId><ArticleId IdType="pmc">PMC6256266</ArticleId><ArticleId IdType="pubmed">29863110</ArticleId></ArticleIdList></Reference><Reference><Citation>He DD, Zhang XK, Zhu XY, Huang FF, Wang Z, Tu JC. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction. Comput Biol Med. 2021;131:104293. doi: 10.1016/j.compbiomed.2021.104293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.104293</ArticleId><ArticleId IdType="pmc">PMC7899014</ArticleId><ArticleId IdType="pubmed">33662681</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu YN, Liu J, Zhang L, Wang Z, Duan DD, Wang YY. Clinical Zheng-hou pharmacology: the missing link between pharmacogenomics and personalized medicine? Curr Vasc Pharmacol. 2015;13:423&#x2013;32. doi: 10.2174/1570161112666141014144431.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570161112666141014144431</ArticleId><ArticleId IdType="pubmed">25360846</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran J. The Yellow Emperor&#x2019;s classic of internal medicine. BMJ. 2008;336:777. doi: 10.1136/bmj.39527.472303.4E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39527.472303.4E</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N, et al. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med. 2020;26:243&#x2013;50. doi: 10.1007/s11655-020-3192-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-020-3192-6</ArticleId><ArticleId IdType="pmc">PMC7088641</ArticleId><ArticleId IdType="pubmed">32065348</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F, Tang W. Traditional Chinese medicine for treatment of novel infectious diseases: current status and dilemma. Biosci Trends. 2021;15:201&#x2013;4. doi: 10.5582/bst.2021.01263.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2021.01263</ArticleId><ArticleId IdType="pubmed">34193750</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Geng H, Feng W, Tang X, Ou A, Lao Y, et al. A follow-up study of 69 discharged SARS patients. J Tradit Chin Med. 2003;23:214&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">14535196</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong X, Li A, Zhang Z, Duan J, Chen X, Hua C, et al. TCM treatment of infectious atypical pneumonia&#x2014;a report of 16 cases. J Tradit Chin Med. 2004;24:266&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15688692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang MM, Liu XM, He L. Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence. World J Gastroenterol. 2004;10:3500&#x2013;5. doi: 10.3748/wjg.v10.i23.3500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v10.i23.3500</ArticleId><ArticleId IdType="pmc">PMC4576235</ArticleId><ArticleId IdType="pubmed">15526373</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Zhang M, He L, Li YP, Kang YK. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS) Cochrane Database Syst Rev. 2006;10:CD004882.</Citation><ArticleIdList><ArticleId IdType="pubmed">16437501</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guo JJ, Healy DP, Zhan S. Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: a meta-analysis. Pharm Pract (Granada). 2007;5:1&#x2013;9. doi: 10.4321/S1886-36552007000100001.</Citation><ArticleIdList><ArticleId IdType="doi">10.4321/S1886-36552007000100001</ArticleId><ArticleId IdType="pmc">PMC4155143</ArticleId><ArticleId IdType="pubmed">25214911</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau JT, Leung PC, Wong EL, Fong C, Cheng KF, Zhang SC, et al. The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study. J Alter Complement Med. 2005;11:49&#x2013;55. doi: 10.1089/acm.2005.11.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2005.11.49</ArticleId><ArticleId IdType="pubmed">15750363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565&#x2013;74. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Han P, Li L, Liu S, Wang Q, Zhang D, Xu Z, et al. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell. 2022;185:630&#x2013;40. doi: 10.1016/j.cell.2022.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.001</ArticleId><ArticleId IdType="pmc">PMC8733278</ArticleId><ArticleId IdType="pubmed">35093192</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Addendum: a pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;588:E6. doi: 10.1038/s41586-020-2951-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2951-z</ArticleId><ArticleId IdType="pmc">PMC9744119</ArticleId><ArticleId IdType="pubmed">33199918</ArticleId></ArticleIdList></Reference><Reference><Citation>Song P, Zhao L, Li X, Su J, Jiang Z, Song B, et al. Interpretation of the Traditional Chinese Medicine portion of the diagnosis and treatment protocol for corona virus disease 2019 (Trial Version 7) J Tradit Chin Med. 2020;40:497&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">32506865</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wang H, Li X, Zheng Y, Wei Y, Zhang P, et al. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China. Front Med. 2020;14:681&#x2013;8. doi: 10.1007/s11684-020-0801-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0801-x</ArticleId><ArticleId IdType="pmc">PMC7348116</ArticleId><ArticleId IdType="pubmed">32651936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Su W, Yang J, Luo D, Xia P, Jia W, et al. Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study. Front Med. 2020;14:752&#x2013;9. doi: 10.1007/s11684-020-0813-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0813-6</ArticleId><ArticleId IdType="pmc">PMC7488644</ArticleId><ArticleId IdType="pubmed">32926320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang J, Dai X, Wu Q, Cai H, Fu X, Zhang W, et al. A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19) Complement Ther Med. 2021;60:102754. doi: 10.1016/j.ctim.2021.102754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctim.2021.102754</ArticleId><ArticleId IdType="pmc">PMC8213518</ArticleId><ArticleId IdType="pubmed">34153446</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Li Y, Zhou L, Zhou X, Xie B, Zhang W, et al. Prevention and treatment of COVID-19 using traditional Chinese medicine: a review. Phytomedicine. 2021;85:153308. doi: 10.1016/j.phymed.2020.153308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2020.153308</ArticleId><ArticleId IdType="pmc">PMC7439087</ArticleId><ArticleId IdType="pubmed">32843234</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Huang F, Zhang M, Huang B, Wang Y. Current status of traditional Chinese medicine for the treatment of COVID-19 in China. Chin Med. 2021;16:63. doi: 10.1186/s13020-021-00461-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-021-00461-y</ArticleId><ArticleId IdType="pmc">PMC8314260</ArticleId><ArticleId IdType="pubmed">34315521</ArticleId></ArticleIdList></Reference><Reference><Citation>Buabeid M, Ijaz M, Shamim S, Huang X, Murtaza G. Therapeutic uses of traditional chinese medicines against COVID-19. Infect Drug Resist. 2021;14:5017&#x2013;26. doi: 10.2147/IDR.S328261.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S328261</ArticleId><ArticleId IdType="pmc">PMC8639285</ArticleId><ArticleId IdType="pubmed">34866921</ArticleId></ArticleIdList></Reference><Reference><Citation>An X, Zhang Y, Duan L, Jin, Zhao S, Zhou R, et al. The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19. Biomed Pharmacother. 2021;137:111267. doi: 10.1016/j.biopha.2021.111267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111267</ArticleId><ArticleId IdType="pmc">PMC7836975</ArticleId><ArticleId IdType="pubmed">33508618</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Yan S, Wang H, Zhang Y, Zheng Y, Wu H, et al. Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: a cohort study. Pharmacol Res. 2020;161:105127. doi: 10.1016/j.phrs.2020.105127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105127</ArticleId><ArticleId IdType="pmc">PMC7416080</ArticleId><ArticleId IdType="pubmed">32791263</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai Z, Zhou S, Li W, Wang M, Wang L, Hu G, et al. &#x201c;Fei Yan No. 1&#x201d; as a combined treatment for COVID-19: an efficacy and potential mechanistic study. Front Pharmacol. 2020;11:581277. doi: 10.3389/fphar.2020.581277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.581277</ArticleId><ArticleId IdType="pmc">PMC7580177</ArticleId><ArticleId IdType="pubmed">33132913</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Zhang B, Lv JT, Sa RN, Zhang XM, Lin ZJ. The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. Pharmacol Res. 2020;157:104882. doi: 10.1016/j.phrs.2020.104882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104882</ArticleId><ArticleId IdType="pmc">PMC7198419</ArticleId><ArticleId IdType="pubmed">32380051</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Chen Z, Sun X, Zhong N, Liu Z. Application of traditional chinese medicine and systems pharmacology in drug prevention and treatment against COVID-19. Am J Chin Med. 2021;49:1045&#x2013;61. doi: 10.1142/S0192415X21500506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X21500506</ArticleId><ArticleId IdType="pubmed">34225580</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou LP, Wang J, Xie RH, Pakhale S, Krewski D, Cameron DW, et al. The effects of traditional Chinese medicine as an auxiliary treatment for COVID-19: a systematic review and meta-analysis. J Alter Complement Med. 2021;27:225&#x2013;37. doi: 10.1089/acm.2020.0310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2020.0310</ArticleId><ArticleId IdType="pubmed">33252246</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Jin, Lin J, Zhang Y, Tian J, Lian F, et al. Understanding COVID-19 in Wuhan from the perspective of cold-dampness: clinical evidences and mechanisms. Front Med. 2021;8:617659. doi: 10.3389/fmed.2021.617659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.617659</ArticleId><ArticleId IdType="pmc">PMC7939017</ArticleId><ArticleId IdType="pubmed">33693014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao ZH, Zhou Y, Li WH, Huang QS, Tang ZH, Li H. Analysis of traditional Chinese medicine diagnosis and treatment strategies for COVID-19 based on &#x201c;The Diagnosis and Treatment Program for Coronavirus Disease-2019&#x201d; from Chinese authority. Am J Chin Med. 2020;48:1035&#x2013;49. doi: 10.1142/S0192415X20500500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X20500500</ArticleId><ArticleId IdType="pubmed">32668970</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K, Zhang P, Zhang Z, Youn JY, Wang C, Zhang H, et al. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharmacol Ther. 2021;225:107843. doi: 10.1016/j.pharmthera.2021.107843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2021.107843</ArticleId><ArticleId IdType="pmc">PMC8011334</ArticleId><ArticleId IdType="pubmed">33811957</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wu Y, Chen C, Gu Y, Zhu C, Wang S, et al. Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening. Acta Pharm Sin B. 2021;11:222&#x2013;36. doi: 10.1016/j.apsb.2020.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7547831</ArticleId><ArticleId IdType="pubmed">33072499</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, et al. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res. 2021;20:3315&#x2013;29. doi: 10.1021/acs.jproteome.1c00224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippetti L, Pace N, Louis JS, Mandry D, Goehringer F, Rocher MS, et al. Long-lasting myocardial and skeletal muscle damage evidenced by serial CMR during the first year in COVID-19 patients from the first wave. Front Cardiovasc Med. 2022;9:831580. doi: 10.3389/fcvm.2022.831580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.831580</ArticleId><ArticleId IdType="pmc">PMC8959613</ArticleId><ArticleId IdType="pubmed">35355964</ArticleId></ArticleIdList></Reference><Reference><Citation>Szarpak L, Pruc M, Filipiak KJ, Popieluch J, Bielski A, Jaguszewski MJ, et al. Myocarditis: a complication of COVID-19 and long-COVID-19 syndrome as a serious threat in modern cardiology. Cardiol J. 2022;29:178&#x2013;9. doi: 10.5603/CJ.a2021.0155.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2021.0155</ArticleId><ArticleId IdType="pmc">PMC8890406</ArticleId><ArticleId IdType="pubmed">34811716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>